NHS whole-gene screening helps tailor cancer care

DealsHealth 17 November 2023, 11:31 am 1 minute Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies.  Market…

Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale.  Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….

Stars and doctors hope Russell T Davies’s BBC drama Men Up can help end impotence stigma.

For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the maker…

“Drink in moderation” is advice we hear often, but as most people can attest to after a booze-filled holiday season, it isn’t easy to stick to. When we can stick to moderate drinking, however, we usually feel pretty good about ourselves. According to the 2020-2025 Dietary Guidelines for Americans, moderate drinking is defined as no…

It’s the most wonderful time of the year ― unless you’re on a diet and have set impossible standards for eating during the holidays. There’s nothing wrong with taking an “everything in moderation” approach at the dinner table, but other “rules” we establish for ourselves around the holidays can actually hinder rather than help our…